Cargando…
Patient-derived cell models as preclinical tools for genome-directed targeted therapy
BACKGROUND: In this study, we established patient-derived tumor cell (PDC) models using tissues collected from patients with metastatic cancer and assessed whether these models could be used as a tool for genome-based cancer treatment. METHODS: PDCs were isolated and cultured from malignant effusion...
Autores principales: | Lee, Ji Yun, Kim, Sun Young, Park, Charny, Kim, Nayoung K.D., Jang, Jiryeon, Park, Kyunghee, Yi, Jun Ho, Hong, Mineui, Ahn, Taejin, Rath, Oliver, Schueler, Julia, Kim, Seung Tae, Do, In-Gu, Lee, Sujin, Park, Se Hoon, Ji, Yong Ick, Kim, Dukwhan, Park, Joon Oh, Park, Young Suk, Kang, Won Ki, Kim, Kyoung-Mee, Park, Woong-Yang, Lim, Ho Yeong, Lee, Jeeyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694854/ https://www.ncbi.nlm.nih.gov/pubmed/26296973 |
Ejemplares similares
-
MerTK is a novel therapeutic target in gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2015) -
An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients
por: Lee, Ji Yun, et al.
Publicado: (2017) -
Gastrointestinal malignancies harbor actionable MET exon 14 deletions
por: Lee, Jeeyun, et al.
Publicado: (2015) -
BEZ235 (PIK3/mTOR inhibitor) Overcomes Pazopanib Resistance in Patient-Derived Refractory Soft Tissue Sarcoma Cells
por: Kim, Hee Kyung, et al.
Publicado: (2016) -
Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer
por: Yi, Jun Ho, et al.
Publicado: (2014)